Daniel A Lemberg

Author PubWeight™ 42.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Probiotics: sorting the evidence from the myths. Med J Aust 2008 2.21
2 Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease. J Clin Microbiol 2008 2.06
3 Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol 2007 1.88
4 Eosinophilic esophagitis in children with celiac disease. J Gastroenterol Hepatol 2007 1.74
5 Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease. Inflamm Bowel Dis 2010 1.69
6 Development and assessment of a modified Pediatric Crohn Disease Activity Index. J Pediatr Gastroenterol Nutr 2010 1.40
7 Defensins and inflammation: the role of defensins in inflammatory bowel disease. J Gastroenterol Hepatol 2009 1.24
8 Isolation and detection of Campylobacter concisus from saliva of healthy individuals and patients with inflammatory bowel disease. J Clin Microbiol 2010 1.20
9 Vitamin D deficiency in children with inflammatory bowel disease. Dig Dis Sci 2011 1.18
10 Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach. J Gastroenterol Hepatol 2006 1.16
11 Update of fecal markers of inflammation in inflammatory bowel disease. J Gastroenterol Hepatol 2011 1.13
12 Microbial dysbiosis in pediatric patients with Crohn's disease. J Clin Microbiol 2012 1.10
13 Crohn's and colitis in children and adolescents. World J Gastroenterol 2012 1.10
14 Comment to: Changes of faecal microflora in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition. Dig Liver Dis 2012 1.09
15 The pathogenic potential of Campylobacter concisus strains associated with chronic intestinal diseases. PLoS One 2011 1.00
16 The prevalence and polymorphisms of zonula occluden toxin gene in multiple Campylobacter concisus strains isolated from saliva of patients with inflammatory bowel disease and controls. PLoS One 2013 1.00
17 Inflammatory bowel disease therapies and gut function in a colitis mouse model. Biomed Res Int 2013 1.00
18 An update of the role of nutritional therapy in the management of Crohn's disease. J Gastroenterol 2012 0.99
19 Esophageal subepithelial fibrosis and hyalinization are features of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2011 0.95
20 Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease. Inflamm Bowel Dis 2008 0.94
21 C-reactive protein and disease activity in children with Crohn's disease. Dig Dis Sci 2010 0.91
22 Congenital short bowel syndrome: a case report and review of the literature. Can J Gastroenterol 2008 0.89
23 Infliximab improves inflammation and anthropometric measures in pediatric Crohn's disease. J Gastroenterol Hepatol 2010 0.86
24 Detection of Helicobacteraceae in intestinal biopsies of children with Crohn's disease. Helicobacter 2010 0.86
25 Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activation. Dig Dis Sci 2013 0.85
26 Exclusive enteral nutrition in the management of perianal Crohn's disease in children. J Dig Dis 2010 0.84
27 Differential effects of nutritional and non-nutritional therapies on intestinal barrier function in an in vitro model. J Gastroenterol 2011 0.82
28 Complementary and alternative medicine in children attending gastroenterology clinics: usage patterns and reasons for use. J Paediatr Child Health 2011 0.81
29 Assessment of nutritional status and serum leptin in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011 0.80
30 Osteoprotegerin in pediatric Crohn's disease and the effects of exclusive enteral nutrition. Inflamm Bowel Dis 2011 0.79
31 Dietary intakes of children with Crohn's disease. Br J Nutr 2009 0.78
32 Campylobacter concisus and exotoxin 9 levels in paediatric patients with Crohn's disease and their association with the intestinal microbiota. J Med Microbiol 2013 0.78
33 Single High-Dose Oral Vitamin D3 Therapy (Stoss): A Solution to Vitamin D Deficiency in Children With Inflammatory Bowel Disease? J Pediatr Gastroenterol Nutr 2015 0.77
34 Low rate of inflammatory bowel disease in the Australian indigenous paediatric population. J Paediatr Child Health 2014 0.77
35 Thiopurine-induced pancreatitis in inflammatory bowel diseases. Expert Rev Gastroenterol Hepatol 2014 0.77
36 Family adjustment and parenting stress when an infant has serious liver disease: the Australian experience. J Pediatr Gastroenterol Nutr 2015 0.77
37 Campylobacter concisus: a new character in the Crohn's disease story? J Clin Microbiol 2009 0.76
38 The major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based analysis. Genes Nutr 2015 0.75
39 Markers of inflammation in the breath in paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2014 0.75
40 Subclinical intestinal inflammation in siblings of children with Crohn's disease. Dig Dis Sci 2010 0.75
41 Are thiopurines always contraindicated after thiopurine-induced pancreatitis in inflammatory bowel disease? J Pediatr Gastroenterol Nutr 2013 0.75
42 A case of duodenal web occurring in Prader-Willi syndrome. J Paediatr Child Health 2005 0.75
43 Generalisability of the inflammatory bowel disease knowledge inventory device to assess disease-related knowledge in Australian children. J Paediatr Child Health 2014 0.75
44 Family Impact and Infant Emotional Outcomes Following Diagnosis of Serious Liver Disease or Transplantation in Infancy. J Pediatr Gastroenterol Nutr 2016 0.75